These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 32879176

  • 1. [Pharmacological action and clinical effect of tedizolid phosphate (SIVEXTRO® Tablets 200 mg, for iv infusion 200 mg), a novel oxazolidinone-class antibacterial drug].
    Mori M, Takase A.
    Nihon Yakurigaku Zasshi; 2020; 155(5):332-339. PubMed ID: 32879176
    [Abstract] [Full Text] [Related]

  • 2. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG, Love R, Adam H, Golden A, Zelenitsky S, Schweizer F, Gorityala B, Lagacé-Wiens PR, Rubinstein E, Walkty A, Gin AS, Gilmour M, Hoban DJ, Lynch JP, Karlowsky JA.
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections.
    Prokocimer P, Bien P, Deanda C, Pillar CM, Bartizal K.
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4608-13. PubMed ID: 22687509
    [Abstract] [Full Text] [Related]

  • 4. Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.
    Rybak JM, Marx K, Martin CA.
    Pharmacotherapy; 2014 Nov; 34(11):1198-208. PubMed ID: 25266820
    [Abstract] [Full Text] [Related]

  • 5. Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model.
    Lepak AJ, Marchillo K, Pichereau S, Craig WA, Andes DR.
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5916-22. PubMed ID: 22964254
    [Abstract] [Full Text] [Related]

  • 6. In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016.
    Karlowsky JA, Hackel MA, Bouchillon SK, Alder J, Sahm DF.
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):151-157. PubMed ID: 28793964
    [Abstract] [Full Text] [Related]

  • 7. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
    Chen KH, Huang YT, Liao CH, Sheng WH, Hsueh PR.
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone.
    Zurenko G, Bien P, Bensaci M, Patel HN, Thorne G.
    Ann Clin Microbiol Antimicrob; 2014 Sep 20; 13():46. PubMed ID: 25238753
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China.
    Biedenbach DJ, Bouchillon SK, Johnson B, Alder J, Sahm DF.
    Eur J Clin Microbiol Infect Dis; 2016 Dec 20; 35(12):1933-1939. PubMed ID: 27677280
    [Abstract] [Full Text] [Related]

  • 11. Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan - Results of a randomised, multicentre phase 3 study.
    Mikamo H, Takesue Y, Iwamoto Y, Tanigawa T, Kato M, Tanimura Y, Kohno S.
    J Infect Chemother; 2018 Jun 20; 24(6):434-442. PubMed ID: 29530544
    [Abstract] [Full Text] [Related]

  • 12. An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections.
    Delpech P, ALeryan M, Jones B, Gemmell C, Lang S.
    Diagn Microbiol Infect Dis; 2018 May 20; 91(1):93-97. PubMed ID: 29452993
    [Abstract] [Full Text] [Related]

  • 13. Tedizolid phosphate for the treatment of acute bacterial skin and skin structure infections.
    Gras J.
    Drugs Today (Barc); 2014 Nov 20; 50(11):729-37. PubMed ID: 25525633
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.
    Sahm DF, Deane J, Bien PA, Locke JB, Zuill DE, Shaw KJ, Bartizal KF.
    Diagn Microbiol Infect Dis; 2015 Feb 20; 81(2):112-8. PubMed ID: 25488274
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid.
    Vanegas Múnera JM, Ocampo Ríos AM, Urrego DM, Jiménez Quiceno JN.
    Braz J Infect Dis; 2017 Feb 20; 21(5):493-499. PubMed ID: 28432878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model.
    Louie A, Liu W, Kulawy R, Drusano GL.
    Antimicrob Agents Chemother; 2011 Jul 20; 55(7):3453-60. PubMed ID: 21502615
    [Abstract] [Full Text] [Related]

  • 19. Antibacterial Activity of Tedizolid, a Novel Oxazolidinone Against Methicillin-Resistant Staphylococcus aureus: A Systematic Review and Meta-Analysis.
    Hasannejad-Bibalan M, Mojtahedi A, Biglari H, Halaji M, Sedigh Ebrahim-Saraie H.
    Microb Drug Resist; 2019 Nov 20; 25(9):1330-1337. PubMed ID: 31290721
    [Abstract] [Full Text] [Related]

  • 20. Tedizolid: a new oxazolidinone antimicrobial.
    Kisgen JJ, Mansour H, Unger NR, Childs LM.
    Am J Health Syst Pharm; 2014 Apr 15; 71(8):621-33. PubMed ID: 24688035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.